Trends and Gaps in Digital Precision Hypertension Management: Scoping Review
- PMID: 39928934
- PMCID: PMC11851032
- DOI: 10.2196/59841
Trends and Gaps in Digital Precision Hypertension Management: Scoping Review
Abstract
Background: Hypertension (HTN) is the leading cause of cardiovascular disease morbidity and mortality worldwide. Despite effective treatments, most people with HTN do not have their blood pressure under control. Precision health strategies emphasizing predictive, preventive, and personalized care through digital tools offer notable opportunities to optimize the management of HTN.
Objective: This scoping review aimed to fill a research gap in understanding the current state of precision health research using digital tools for the management of HTN in adults.
Methods: This study used a scoping review framework to systematically search for articles in 5 databases published between 2013 and 2023. The included articles were thematically analyzed based on their precision health focus: personalized interventions, prediction models, and phenotyping. Data were extracted and summarized for study and sample characteristics, precision health focus, digital health technology, disciplines involved, and characteristics of personalized interventions.
Results: After screening 883 articles, 46 were included; most studies had a precision health focus on personalized digital interventions (34/46, 74%), followed by prediction models (8/46, 17%) and phenotyping (4/46, 9%). Most studies (38/46, 82%) were conducted in or used data from North America or Europe, and 63% (29/46) of the studies came exclusively from the medical and health sciences, with 33% (15/46) of studies involving 2 or more disciplines. The most commonly used digital technologies were mobile phones (33/46, 72%), blood pressure monitors (18/46, 39%), and machine learning algorithms (11/46, 24%). In total, 45% (21/46) of the studies either did not report race or ethnicity data (14/46, 30%) or partially reported this information (7/46, 15%). For personalized intervention studies, nearly half (14/30, 47%) used 2 or less types of data for personalization, with only 7% (2/30) of the studies using social determinants of health data and no studies using physical environment or digital literacy data. Personalization characteristics of studies varied, with 43% (13/30) of studies using fully automated personalization approaches, 33% (10/30) using human-driven personalization, and 23% (7/30) using a hybrid approach.
Conclusions: This scoping review provides a comprehensive mapping of the literature on the current trends and gaps in digital precision health research for the management of HTN in adults. Personalized digital interventions were the primary focus of most studies; however, the review highlighted the need for more precise definitions of personalization and the integration of more diverse data sources to improve the tailoring of interventions and promotion of health equity. In addition, there were significant gaps in the reporting of race and ethnicity data of participants, underuse of wearable devices for passive data collection, and the need for greater interdisciplinary collaboration to advance precision health research in digital HTN management.
Trial registration: OSF Registries osf.io/yuzf8; https://osf.io/yuzf8.
Keywords: algorithms; digital health; hypertension; machine learning; mobile apps; mobile health; personalization; phenotyping; precision health; prediction models.
©Namuun Clifford, Rachel Tunis, Adetimilehin Ariyo, Haoxiang Yu, Hyekyun Rhee, Kavita Radhakrishnan. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 10.02.2025.
Conflict of interest statement
Conflicts of Interest: Authors NC and AA were supported by the National Institute of Nursing Research of the National Institutes of Health (Award Number T32NR019035, Precision Health Intervention Methodology Training in Self-Management of Multiple Chronic Conditions). The funding agency played no role in the design, data collection, analysis, or writing of the manuscript.
Figures
References
-
- Hypertension. World Health Organization. 2023. Mar 16, [2024-04-29]. https://www.who.int/news-room/fact-sheets/detail/hypertension .
-
- GBD 2017 Risk Factor Collaborators Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923–94. doi: 10.1016/S0140-6736(18)32225-6. https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(18)32225-6 S0140-6736(18)32225-6 - DOI - PMC - PubMed
-
- NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957–80. doi: 10.1016/S0140-6736(21)01330-1. http://hdl.handle.net/2318/1805296 S0140-6736(21)01330-1 - DOI - PMC - PubMed
-
- Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021 Nov 28;18(11):785–802. doi: 10.1038/s41569-021-00559-8. https://europepmc.org/abstract/MED/34050340 10.1038/s41569-021-00559-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
